Filed: 5/15/2023ACC: 0000950123-23-005263
📋 What this filing means
OMEGA FUND MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 14 equity positions with a total reported market value of $153.32M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
14
Positions
$153.32M
Total AUM (reported)
35.02M
Total Shares
Allocation by class
COMMON STOCK$128.30M83.7%
COMMON STOCK CLASS A$25.02M16.3%
Portfolio Concentration
Top 3$101.38M66.1%
4–10$47.86M31.2%
11–25$4.08M2.7%
Top 3 weight
66.1%
Top 10 weight
97.3%
Voting Authority Distribution
Total shares with voting rights: 35.02M
Sole
Full voting authority
35.02M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole14
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings14
Rows:
Replimune Group
SOLEShares3.05M
TypeSH
Market value$53.87M
35.13%
Sole
3.05M
Shared
0.00
None
0.00
Nuvation Bio
SOLEShares15.07M
TypeSH
Market value$25.02M
16.32%
Sole
15.07M
Shared
0.00
None
0.00
Morphic Holding
SOLEShares597.72K
TypeSH
Market value$22.50M
14.67%
Sole
597.72K
Shared
0.00
None
0.00
Alpine Immune Sciences
SOLEShares2.03M
TypeSH
Market value$15.67M
10.22%
Sole
2.03M
Shared
0.00
None
0.00
Ikena Oncology
SOLEShares2.25M
TypeSH
Market value$7.76M
5.06%
Sole
2.25M
Shared
0.00
None
0.00
Theseus Pharmaceuticals
SOLEShares711.48K
TypeSH
Market value$6.32M
4.12%
Sole
711.48K
Shared
0.00
None
0.00
Kronos Bio
SOLEShares3.82M
TypeSH
Market value$5.57M
3.64%
Sole
3.82M
Shared
0.00
None
0.00
Paratek Pharmaceuticals
SOLEShares1.97M
TypeSH
Market value$5.01M
3.27%
Sole
1.97M
Shared
0.00
None
0.00
Spruce Biosciences
SOLEShares2.16M
TypeSH
Market value$4.78M
3.11%
Sole
2.16M
Shared
0.00
None
0.00
Sana Biotechnology, Inc.
SOLEShares843.75K
TypeSH
Market value$2.76M
1.80%
Sole
843.75K
Shared
0.00
None
0.00
Immunic Inc
SOLEShares1.79M
TypeSH
Market value$2.66M
1.74%
Sole
1.79M
Shared
0.00
None
0.00
Syros Pharmaceuticals
SOLEShares251.27K
TypeSH
Market value$670.9K
0.44%
Sole
251.27K
Shared
0.00
None
0.00
Jounce Therapeutics
SOLEShares275.51K
TypeSH
Market value$509.7K
0.33%
Sole
275.51K
Shared
0.00
None
0.00
Senti Biosciences, Inc.
SOLEShares195.79K
TypeSH
Market value$231.0K
0.15%
Sole
195.79K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Replimune GroupSOLE | Common Stock | 3.05M | SH | $53.87M 35.13% | 3.05M | 0.00 | 0.00 |
Nuvation BioSOLE | Common Stock Class A | 15.07M | SH | $25.02M 16.32% | 15.07M | 0.00 | 0.00 |
Morphic HoldingSOLE | Common Stock | 597.72K | SH | $22.50M 14.67% | 597.72K | 0.00 | 0.00 |
Alpine Immune SciencesSOLE | Common Stock | 2.03M | SH | $15.67M 10.22% | 2.03M | 0.00 | 0.00 |
Ikena OncologySOLE | Common Stock | 2.25M | SH | $7.76M 5.06% | 2.25M | 0.00 | 0.00 |
Theseus PharmaceuticalsSOLE | Common Stock | 711.48K | SH | $6.32M 4.12% | 711.48K | 0.00 | 0.00 |
Kronos BioSOLE | Common Stock | 3.82M | SH | $5.57M 3.64% | 3.82M | 0.00 | 0.00 |
Paratek PharmaceuticalsSOLE | Common Stock | 1.97M | SH | $5.01M 3.27% | 1.97M | 0.00 | 0.00 |
Spruce BiosciencesSOLE | Common Stock | 2.16M | SH | $4.78M 3.11% | 2.16M | 0.00 | 0.00 |
Sana Biotechnology, Inc.SOLE | Common Stock | 843.75K | SH | $2.76M 1.80% | 843.75K | 0.00 | 0.00 |
Immunic IncSOLE | Common Stock | 1.79M | SH | $2.66M 1.74% | 1.79M | 0.00 | 0.00 |
Syros PharmaceuticalsSOLE | Common Stock | 251.27K | SH | $670.9K 0.44% | 251.27K | 0.00 | 0.00 |
Jounce TherapeuticsSOLE | Common Stock | 275.51K | SH | $509.7K 0.33% | 275.51K | 0.00 | 0.00 |
Senti Biosciences, Inc.SOLE | Common Stock | 195.79K | SH | $231.0K 0.15% | 195.79K | 0.00 | 0.00 |